RE:Eight Capital: Buy rating and C$12.00 target for WELL Health
Thanks for posting link. Well worth a read. I like their synopsis of the earnings conference, below:
Conference call takeaways:
• US Telehealth key growth driver. Management decomposed the US$80M
run-rate offered in March as equal contributions of US$40M from Circle and
WISP. WISP is noted to be higher margin and more scalable given the nature
of its recurring fulfillment services. The company is considering strategic
options here, such as an IPO or bringing in a strategic investor.
•Leveraging CRH IP. We believe the hemorrhoid banding clinics (WELL
operates three currently and targets 10 by year-end) are a strategic
opportunity to leverage O’Regan IP and WELL’s ability to own and operate
clinics.
• Canadian business updates. Management noted Canadian business units
are performing well, including segments such as EMR, referral, and
cybersecurity. The company plans to roll out a bundled platform that we
believe will likely enhance cross-sell, consolidating offerings such as practice
management, back-office billing, and revenue cycle management.